TrialJournal of clinical oncology : official journal of the American Society of Clinical Oncology2015

Phase II Study of Gemcitabine, Carboplatin, and Iniparib As Neoadjuvant Therapy for Triple-Negative and BRCA1/2 Mutation-Associated Breast Cancer With Assessment of a Tumor-Based Measure of Genomic Instability: PrECOG 0105.

Melinda L Telli et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.